产品描述: | Tubacin is a highly potent and selective, reversible, cell-permeable HDAC6 inhibitor with an IC50 of 4 nM, approximately 350-fold selectivity over HDAC1. |
靶点: |
HDAC;Virus Protease;VirusProtease; HDAC |
体内研究: |
In chick embryos, inhibition of HDAC6 activity by Tubacin reduces the formation of new blood vessels in matrigel/nylon mesh. In angioreactors implanted in mice, Tubacin also impairs the formation of new blood vessels. |
细胞实验: |
Cell lines: Drug-sensitive (MM.1S,U266,INA-6,and RPMI8226) and drug-resistant (RPMI-LR5 and RPMI-Dox40) MM cell lines. Concentrations: ~20 μM. Incubation Time: 72 hours. Method:The inhibitory effect of bortezomib and/or tubacin on MM cell growth is assessed by measuring 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) dye absorbance.All experiments are performed in quadruplicate. |
动物实验: |
Animal Models: Athymic nude mice implanted with angioreactorsFormulation: DMSODosages: --Administration: Tubacin is filled in semiclosed angioreactors, and then implanted into the mice. |
参考文献: |
1. Li D, et al. Protein Cell. 2011, 2(2), 150-160. 2. Butler KV, et al. J Am Chem Soc. 2010, 132(31), 10842-0846. 3. Hideshima T, et al. Proc Natl Acad Sci U S A. 2005, 102(24), 8567-8572. 4. Marcus AI, et al. Cancer Res. 2005, 65(9), 3883-3893. 5. Lu CY, et al. Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis. Int J Mol Sci. 2017 May 1;18(5). 6. Haggarty SJ, et al. Proc Natl Acad Sci U S A. 2003, 100(8), 4389-4394. |
溶解性: |
Soluble in DMSO |
保存条件: |
-20℃ |
配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
1 mM |
1.385 ml |
6.927 ml |
13.853 ml |
5 mM |
0.277 ml |
1.385 ml |
2.771 ml |
10 mM |
0.139 ml |
0.693 ml |
1.385 ml |
50 mM |
0.028 ml |
0.139 ml |
0.277 ml |
|
注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |